Kiora Pharmaceuticals Inc financial data

Symbol
KPRX on Nasdaq, KPHMW on OTC
Location
332 Encinitas Boulevard, Suite 102, Encinitas, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 629 % -43%
Debt-to-equity 38.7 % +3.89%
Return On Assets -34 % -400%
Operating Margin -55.2K % -346268%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.43M shares +15.6%
Common Stock, Shares, Outstanding 3.43M shares +15.6%
Entity Public Float 12.2M USD +157%
Common Stock, Value, Issued 272K USD +1.73%
Weighted Average Number of Shares Outstanding, Basic 3.99M shares -4.35%
Weighted Average Number of Shares Outstanding, Diluted 3.99M shares -4.35%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 0 USD -100%
Research and Development Expense 9.23M USD +55.7%
General and Administrative Expense 5.55M USD +8.19%
Operating Income (Loss) -10.9M USD -513%
Nonoperating Income (Expense) 987K USD +51.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.26M USD -1.93%
Income Tax Expense (Benefit) -112K USD
Net Income (Loss) Attributable to Parent -12M USD -474%
Earnings Per Share, Basic -4 USD/shares +64.3%
Earnings Per Share, Diluted -3 USD/shares +76.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.03M USD -84.4%
Accounts Receivable, after Allowance for Credit Loss, Current 2.42M USD +80.3%
Assets, Current 24.7M USD -22.3%
Property, Plant and Equipment, Net 107K USD +68.3%
Operating Lease, Right-of-Use Asset 349K USD +324%
Intangible Assets, Net (Excluding Goodwill) 6.69M USD -24%
Other Assets, Noncurrent 61K USD +89.9%
Assets 31.9M USD -21.7%
Accounts Payable, Current 283K USD +5.17%
Employee-related Liabilities, Current 828K USD +22.3%
Accrued Liabilities, Current 2.54M USD +88.9%
Liabilities, Current 3.19M USD +92.4%
Contract with Customer, Liability, Noncurrent 1.25M USD
Deferred Income Tax Liabilities, Net 491K USD -37%
Operating Lease, Liability, Noncurrent 287K USD +614%
Liabilities 9.82M USD +27.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -246K USD -0.01%
Retained Earnings (Accumulated Deficit) -148M USD -8.83%
Stockholders' Equity Attributable to Parent 22.1M USD -33.2%
Liabilities and Equity 31.9M USD -21.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.7M USD -120%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 2.67M USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 3.43M shares +15.6%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -21.3K USD -100%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.03M USD -84.3%
Deferred Tax Assets, Valuation Allowance 13.1M USD -60.2%
Deferred Tax Assets, Gross 14.3M USD -58.5%
Operating Lease, Liability 430K USD +423%
Lessee, Operating Lease, Liability, to be Paid 470K USD +406%
Property, Plant and Equipment, Gross 6.26K USD -56.4%
Operating Lease, Liability, Current 143K USD +240%
Lessee, Operating Lease, Liability, to be Paid, Year Two 136K USD +878%
Lessee, Operating Lease, Liability, to be Paid, Year One 172K USD +532%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 39.2K USD +273%
Lessee, Operating Lease, Liability, to be Paid, Year Three 85.6K USD +514%
Deferred Tax Assets, Operating Loss Carryforwards 9.24M USD -64.4%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 11.5K USD
Additional Paid in Capital 170M USD +0.59%
Depreciation, Depletion and Amortization 318 USD -93.5%
Deferred Tax Assets, Net of Valuation Allowance 1.2M USD -20.6%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%